Arintra vs Synthpop

Arintra and Synthpop sit at opposite ends of the revenue cycle. Synthpop takes referral documents and, the vendor says, turns them into payor-ready orders in under a minute, then handles patient outreach over voice and digital channels. MedBridge is the customer shown, a US$15M Series A was announced in February 2026, and a compliance agent reviews orders for pathology labs against CAP and CLIA frameworks. DME suppliers, home infusion operators and labs are the buyers.

Arintra codes charts and says most charts go straight to billing. It lists Epic through Toolbox and athenahealth through its Marketplace, and hospital and group coding directors buy it. Its denial intelligence drafts appeals from the coding audit trail. Synthpop's pages describe intake, eligibility and authorization, while Arintra's describe coding, documentation and denial appeals.